NCT00889603View on ClinicalTrials.gov

Non-Interventional Study With Aricept® Evess

CompletedOBSERVATIONAL
Enrollment

370

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Alzheimer's DiseaseVascular Dementia
Interventions
DRUG

Aricept® Evess

"5 mg film-coated orodispersible tablets, 10 mg film-coated orodispersible tablets.~Treatment may be started with 5 mg donepezil/ day (once-a-day dosing) and after four weeks can be titrated to 10 mg/day (once-a-day dosing)."

Trial Locations (12)

400001

Pfizer Investigational Site, Cluj-Napoca

600114

Pfizer Investigational Site, Bacau

700282

Pfizer Investigational Site, Iași

Pfizer Investigational Site, Iași

Unknown

Pfizer Investigational Site, Cluj-Napoca

Pfizer Investigational Site, Constanța

Pfizer Investigational Site, Craiova

Pfizer Investigational Site, Ploieşti

Pfizer Investigational Site, Timișoara

Pfizer Investigational Site, Bucharest

041902

Pfizer Investigational Site, Bucharest

061301

Pfizer Investigational Site, Bucharest

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00889603 - Non-Interventional Study With Aricept® Evess | Biotech Hunter | Biotech Hunter